Genetically Modified Insect Cell Lines for Stable AAV Production

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current insect cell lines used for AAV production and protein expression, such as those derived from Spodoptera frugiperda, face limitations in maintaining high productivity and quality as they age, with low-passage cells being necessary for optimal performance, which can be impractical for large-scale production.

Innovation Solution

Development of genetically modified insect cell lines that constitutively express baculovirus IE1, characterized by shorter doubling times and significantly increased AAV production yields, derived from lepidopteran insects like Spodoptera frugiperda, Trichoplusia ni, or Bombyx mori, which are adapted for high-passage stability and enhanced productivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional insect cell lines are used for AAV production, then initial productivity is acceptable, but productivity decreases significantly as passage number increases

Engineering Contradiction:
ImproveAAV production yieldVSAvoidcell line stability at high passage
Core Design Contradiction:
ProductivityVSDuration of action of stationary object

Solution Approach 1:

The patent modifies the cell line by introducing baculovirus IE1 gene expression, which changes the biological parameters of the cells to maintain productivity. This genetic modification allows the cells to sustain high AAV production levels even after numerous passages, effectively resolving the degradation issue without changing the fundamental cell line characteristics

Inventive Principle:
Principle #35Parameter changes

2Productivity

If low-passage cells are used to maintain high productivity, then AAV production yield is optimized, but scalability and practical production become limited

Engineering Contradiction:
ImproveAAV production yieldVSAvoidlarge-scale production feasibility
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent performs preliminary genetic modification of the cell line to establish high passage stability before production scaling. By pre-introducing the IE1 expression system, the cell line is prepared in advance to maintain productivity throughout the production process, enabling scalable manufacturing without requiring continuous repassaging to low passage numbers

Inventive Principle:
Principle #10Preliminary action

3Productivity

If insect cell lines are genetically modified to express baculovirus IE1, then AAV production yield increases significantly, but cell line complexity increases

Engineering Contradiction:
ImproveAAV production yieldVSAvoidcell line genetic complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent uses the baculovirus IE1 gene as an intermediary element to enhance AAV production. This single gene acts as a mediator that coordinates multiple functions including cell proliferation control and viral production enhancement, achieving significant productivity improvements without requiring complex multi-gene modifications or sophisticated regulatory networks

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20240352482A1Genetically modified high productivity insect cell lines and methods for obtaining same
Publication Date: 2024.10.24 VIROVEK INC
  • US20240352482A1 patent drawing
  • US20240352482A1 patent drawing
  • US20240352482A1 patent drawing

AI summary

The present disclosure provides a novel genetically modified high productivity VVK-V432C insect cell line derived from the ATCC CRL-1711 cell line. Methods for obtaining this high productivity cell line are also provided.